本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

8.63
-0.4400-4.85%
盘后:8.630.00000.00%16:10 EDT
成交量:15.14万
成交额:131.40万
市值:3.01亿
市盈率:-8.82
高:9.08
开:9.08
低:8.51
收:9.07
52周最高:16.76
52周最低:8.51
股本:3,488.27万
流通股本:1,845.34万
量比:0.83
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-0.9783
每股收益(LYR):-0.9800
净资产收益率:-33.21%
总资产收益率:-22.67%
市净率:1.70
市盈率(LYR):-8.81

数据加载中...

2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/13

重要事件披露

8-K - Current report
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

重要事件披露

8-K - Current report
2022/12/15

SEC问询函

CORRESP [Cover] - Correspondence
2022/12/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/12/12

重要事件披露

8-K - Current report
2022/12/08

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/18

重要事件披露

8-K - Current report
2022/10/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

重要事件披露

8-K - Current report
2022/09/12

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence